Amicus and Shire enter Into $440 million ex-US licensing
agreement to develop and commercialize lysosomal storage disorder
techn
Amicus Therapeutics, Inc. (Cranbury, NJ) announced that it has
entered into a strategic collaboration with Shire Human Genetic
Therapies, Inc. to jointly develop Amicus' three lead
pharmacological . . .
University of Washington obtains United States patent.
University of Washington (Seattle, WA) has patented a method for
identifying a thermostable polymerase having altered fidelity. The
method consists of generating a random population of polymerase . . .
KobayashiKobayashi obtains United States patent.(Brief
article)
Kobayashi has patented a cell line which can be substituted for
.beta. cells in human mature pancreatic islets and express insulin in a
glucose-concentration dependent manner, and enables the easy . . .
The Horticulture and Food Research Institute of New Zealand
obtains United States patent.
The Horticulture and Food Research Institute of New Zealand Limited
(Auckland, New Zealand) has patented a multifunctional germacrene-D
synthase and a polynucleotide encoding it. Included also are . . .
DNAVEC obtains United States patent.
DNAVEC Research, Inc. (Ibaraki, Japan) has patented a recombinant
Sendai virus vector for introducing exogenous genes to airway epithelia
and a method for introducing exogenous genes using the . . .
Patent for delivery of stem cells to human heart issued to
CellCyte Genetics.
CellCyte Genetics Corporation (Kirkland, WA) has received notice of
the issuance of United States Patent 7,282,222) for its unique methods
and compositions approach to deliver and direct stem cells . . .
Ellen obtains United States patent.(Brief article)
Ellen AB (Angelholm, Sweden) has patented isolated strains of
lactic acid producing bacteria of the genera Lactobacillus and
Pediococcus, and a method for isolation of such bacterial . . .
Applied Nanosystems obtains United States patent.(Brief
article)
Applied Nanosystems B.V. (Groningen, Netherlands) has patented a
method of surface display of proteins on microorganisms via the
targeting and anchoring of heterologous proteins to the outer . . .
University of Florida obtains United States patent.
University of Florida Research Foundation, Inc. (Gainesville, FL)
has patented mutant polynucleotide molecules that encode enzymes that
have increased heat stability. These polynucleotides, when . . .
Pharmacopeia and GlaxoSmithKline collaboration identifies two
additional lead compounds.
Pharmacopeia (Princeton, NJ) has identified two new lead compounds
for advancement in its alliance with GlaxoSmithKline , through its
collaboration with the Center of Excellence for External Drug . . .
Non-surgical stem-cell procedure relieves degenerative joint
disease.
Regenerative Sciences, Inc. (Denver, CO) has launched its
patent-pending Regenexx procedure, which uses a patient's own stem
cells to regenerate bone and cartilage -- a welcome relief for the . . .
Novozymes obtains United States patent.
Novozymes A/S (Bagsvaerd, Denmark) has patented a method for
modifying the substrate specificity of a lipolytic enzyme by making
alterations to the amino acid sequence in a defined region of . . .
Essential Skincare obtains United States patent.
Essential Skincare, LLC (Austin, MN) has patented methods for
stimulating proliferation and inhibiting death of cells in the epidermis
and dermis of wounded and non-wounded as well as transplanted . . .
Japan Science and Technology Agency obtains United States
patent.
Japan Science and Technology Agency (Kawaguchi-shi, Japan) has
patented a animal model useful in identifying a molecule controlling in
a lymphocyte-specific manner migration and thus . . .
InterMune buys out license agreement for pirfenidone.
InterMune, Inc. (Brisbane, CA) has entered into agreements with
Marnac, Inc. and with co-licensor KDL GmbH that will eliminate all of
InterMune's future royalty and milestone payment obligations . . .
United States Secretary of the Department of Health and Human
Services obtains United States patent.
The United States Secretary of the Department of Health and Human
Services (Washington, DC) has patented a method of screening for a
compound that binds to a selected nucleic acid comprising . . .
Osel, obtains United States patent.
Osel, Inc. (Santa Clara, CA) has patented Lactobacillus species
recombinantly altered to express a biologically active protein. The
invention also related to methods of providing the bacteria to . . .
Novimmune obtains United States patent.
Novimmune SA (Geneve, Switzerland) has patented monoclonal
antibodies that recognize the Toll-like Receptor 4/MD-2 receptor
complex, and monoclonal antibodies that recognize the TLR4/MD2 complex
as . . .
Innogenetics obtains United States patent.
Innogenetics N.V. (Ghent, Belgium) has patented a method for
detection and/or genetic analysis of HBV in a biological sample,
comprising hybridizing the polynucleic acids of the sample with . . .
Oncolytics announces issuance of 24th patent.
Oncolytics Biotech, Inc. (Calgary, Canada) has been granted United
States Patent 7,300,650 entitled "Reovirus for the Treatment of
Neoplasia." The claims describe methods of using the reovirus . . .
|
|